Identifies 12 moderate risk patients, cause for admission, number of days of in-patient stay and number of days VTE prophylaxis was given of all days admitted and type of prophylaxis given. 12/13 patient did receive prophylaxis on admission (92%), the reason is unknown in the 1 that did not receive prophylaxis.

Table 2: Identifies 12 moderate risk patients, cause for admission, number of days of in-patient stay and number of days VTE prophylaxis was given of all days admitted and type of prophylaxis given. 12/13 patient did receive prophylaxis on admission (92%), the reason is unknown in the 1 that did not receive prophylaxis.

Risk	Admission cause	Day’s prophylaxis given/days of admission	Prophylaxis given	Prophylaxis
Moderate Risk	Infected pressure ulcer R ankle	8 of 9	Yes	Enoxaparin (Clexane)
Moderate Risk	Hyponatraemia, secondary to hypovolaemia, anaemia (GI bleed)			NIL
Moderate Risk	Shortness of breath, productive cough, sore throat	4 of 7	Yes	Enoxaparin (Clexane)
Moderate Risk	Confusion and generally unwell	1 of 3	Yes	Enoxaparin (Clexane)
Moderate Risk	Lower abdominal pain with immunocompromised shingles rash	6 of 7	Yes	Rivaroxaban
Moderate Risk	Worsening shortness of breath, known COPD	0 of 7	NOT NEEDED	Heparin
Moderate Risk	Confusion secondary to cognitive impairment	13 of 15	Yes	Enoxaparin (Clexane)
Moderate Risk	COVID, cough, febrile	8 of 9	NOT NEEDED	Rivaroxiban
Moderate Risk	Fever, unwell, cough	all days	Yes	Apixaban
Moderate Risk	Nausea, vomiting, epigastric discomfort,	5^th till 6^th Dec Heparin, 7^th onwards Clexane	Yes	Clexane, heparin
Moderate Risk	Nausea, vomiting, leg wound, AKI, sepsis	Given regularly	Yes	Enoxaparin (Clexane)
Moderate Risk	Pleuritic chest pain following laparotomy -- PE	Given regularly	Yes	Enoxaparin (Clexane)